CVS Health (CVS) Stock Forecast & Price Target

Compare

13,883 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CVS Analyst Ratings

Strong Buy

13 Buy

2 Hold

0 Sell

Based on 15 analysts giving stock ratings to

CVS

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CVS Stock 12 Month Forecast

Average Price Target

$81.73

▲(24.76% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $81.73 with a high forecast of $99.00 and a low forecast of $67.00. The average price target represents a 24.76% change from the last price of $65.51.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"42":"$42","71":"$71","100":"$100","56.5":"$56.5","85.5":"$85.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":99,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$99.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":81.73,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$81.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$67.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[42,56.5,71,85.5,100],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.47,65.28,68.09,70.9,73.71,76.52,79.33,82.14,84.95,87.75999999999999,90.57,93.38,96.19,{"y":99,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.47,63.95153846153846,65.43307692307692,66.91461538461539,68.39615384615385,69.87769230769231,71.35923076923078,72.84076923076924,74.32230769230769,75.80384615384615,77.28538461538461,78.76692307692308,80.24846153846154,{"y":81.73,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.47,62.818461538461534,63.16692307692308,63.51538461538461,63.863846153846154,64.21230769230769,64.56076923076922,64.90923076923077,65.25769230769231,65.60615384615384,65.95461538461538,66.30307692307693,66.65153846153846,{"y":67,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":57.4,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.73,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.84,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.96,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.12,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.4,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.3,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.35,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.56,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.7,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.91,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.83,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.47,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$99.00

Average Price Target$81.73

Lowest Price Target$67.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Soren Coverra

TR | OpenAI - 4o

$71→$73

Buy

11.43%

Upside

Reiterated

08/11/25

Charles Rhyee

TD Cowen

$99

Buy

51.12%

Upside

Reiterated

08/07/25

CVS Health (CVS) Receives a Buy from TD Cowen

Lisa Gill

J.P. Morgan

$86→$93

Buy

41.96%

Upside

Reiterated

08/06/25

J.P. Morgan Keeps Their Buy Rating on CVS Health (CVS)

David S Macdonald

Truist Financial

$84

Buy

28.22%

Upside

Reiterated

08/04/25

Analysts Offer Insights on Healthcare Companies: Vericel (NASDAQ: VCEL), Evolent Health (NYSE: EVH) and CVS Health (NYSE: CVS)

Ben Hendrix

RBC Capital

$81

Buy

23.65%

Upside

Reiterated

08/03/25

RBC Capital Reaffirms Their Buy Rating on CVS Health (CVS)

Erin Wright

Morgan Stanley

$80→$82

Buy

25.17%

Upside

Reiterated

08/01/25

Morgan Stanley Sticks to Their Buy Rating for CVS Health (CVS)Morgan Stanley analyst Erin Wright raised the price target on CVS Health (NYSE: CVS) to $82.00 (from $80.00) while maintaining a Overweight rating.

Allen Lutz

Bank of America Securities

$85→$89

Buy

35.86%

Upside

Reiterated

08/01/25

CVS Health: Strong Market Position and Financial Performance Drive Buy Rating

Michael Cherny

Leerink Partners

$86

Buy

31.28%

Upside

Reiterated

08/01/25

CVS Health's Positive Trajectory: Strong Q2 Performance and Growth Prospects Drive Buy Rating

Andrew Mok CFA

Barclays

$79→$80

Buy

22.12%

Upside

Reiterated

08/01/25

Analysts' Top Healthcare Picks: Incyte (INCY), CVS Health (CVS)

Elizabeth Anderson CFA

Evercore ISI

$85

Buy

29.75%

Upside

Reiterated

08/01/25

Evercore ISI Keeps Their Buy Rating on CVS Health (CVS)

Kevin Caliendo

UBS

$71→$67

Hold

2.27%

Upside

Reiterated

07/22/25

CVS Health (CVS) Gets a Hold from UBS

Lance Wilkes

Bernstein

$78→$72

Hold

9.91%

Upside

Reiterated

07/16/25

Bernstein Sticks to Their Hold Rating for CVS Health (CVS)

Brian Tanquilut

Jefferies

$80

Buy

22.12%

Upside

Reiterated

06/30/25

Jefferies Keeps Their Buy Rating on CVS Health (CVS)

Stephen Baxter

Wells Fargo

$85→$84

Buy

28.22%

Upside

Reiterated

06/18/25

Wells Fargo Sticks to Its Buy Rating for CVS Health (CVS)

Sarah James

Cantor Fitzgerald

$71

Buy

8.38%

Upside

Upgraded

06/17/25

CVS Health (CVS) was upgraded to a Buy Rating at Cantor Fitzgerald

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Soren Coverra

TR | OpenAI - 4o

$71→$73

Buy

11.43%

Upside

Reiterated

08/11/25

Charles Rhyee

TD Cowen

$99

Buy

51.12%

Upside

Reiterated

08/07/25

CVS Health (CVS) Receives a Buy from TD Cowen

Lisa Gill

J.P. Morgan

$86→$93

Buy

41.96%

Upside

Reiterated

08/06/25

J.P. Morgan Keeps Their Buy Rating on CVS Health (CVS)

David S Macdonald

Truist Financial

$84

Buy

28.22%

Upside

Reiterated

08/04/25

Analysts Offer Insights on Healthcare Companies: Vericel (NASDAQ: VCEL), Evolent Health (NYSE: EVH) and CVS Health (NYSE: CVS)

Ben Hendrix

RBC Capital

$81

Buy

23.65%

Upside

Reiterated

08/03/25

RBC Capital Reaffirms Their Buy Rating on CVS Health (CVS)

Erin Wright

Morgan Stanley

$80→$82

Buy

25.17%

Upside

Reiterated

08/01/25

Allen Lutz

Bank of America Securities

$85→$89

Buy

35.86%

Upside

Reiterated

08/01/25

CVS Health: Strong Market Position and Financial Performance Drive Buy Rating

Michael Cherny

Leerink Partners

$86

Buy

31.28%

Upside

Reiterated

08/01/25

CVS Health's Positive Trajectory: Strong Q2 Performance and Growth Prospects Drive Buy Rating

Andrew Mok CFA

Barclays

$79→$80

Buy

22.12%

Upside

Reiterated

08/01/25

Analysts' Top Healthcare Picks: Incyte (INCY), CVS Health (CVS)

Elizabeth Anderson CFA

Evercore ISI

$85

Buy

29.75%

Upside

Reiterated

08/01/25

Evercore ISI Keeps Their Buy Rating on CVS Health (CVS)

Kevin Caliendo

UBS

$71→$67

Hold

2.27%

Upside

Reiterated

07/22/25

CVS Health (CVS) Gets a Hold from UBS

Lance Wilkes

Bernstein

$78→$72

Hold

9.91%

Upside

Reiterated

07/16/25

Bernstein Sticks to Their Hold Rating for CVS Health (CVS)

Brian Tanquilut

Jefferies

$80

Buy

22.12%

Upside

Reiterated

06/30/25

Jefferies Keeps Their Buy Rating on CVS Health (CVS)

Stephen Baxter

Wells Fargo

$85→$84

Buy

28.22%

Upside

Reiterated

06/18/25

Wells Fargo Sticks to Its Buy Rating for CVS Health (CVS)

Sarah James

Cantor Fitzgerald

$71

Buy

8.38%

Upside

Upgraded

06/17/25

CVS Health (CVS) was upgraded to a Buy Rating at Cantor Fitzgerald

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

1 Month

xxx

Success Rate

18/27 ratings generated profit

Average Return

+1.36%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +1.36% per trade.

3 Months

xxx

Success Rate

18/30 ratings generated profit

Average Return

+1.41%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +1.41% per trade.

1 Year

Michael ChernyLeerink Partners

Success Rate

19/34 ratings generated profit

Average Return

+6.71%

reiterated a buy rating 13 days ago

Copying Michael Cherny's trades and holding each position for 1 Year would result in 55.88% of your transactions generating a profit, with an average return of +6.71% per trade.

2 Years

xxx

Success Rate

15/21 ratings generated profit

Average Return

+15.11%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +15.11% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CVS Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CVS has received 30 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the past 3 months is 81.73.

Each month's total comprises the sum of three months' worth of ratings.

CVS Financial Forecast

CVS Earnings Forecast

Next quarter’s earnings estimate for CVS is $1.39 with a range of $1.21 to $1.55. The previous quarter’s EPS was $1.81. CVS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.33% of the time in the same period. In the last calendar year CVS has Outperformed its overall industry.

CVS Sales Forecast

Next quarter’s sales forecast for CVS is $98.56B with a range of $95.53B to $102.92B. The previous quarter’s sales results were $98.94B. CVS beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.70% of the time in the same period. In the last calendar year CVS has Outperformed its overall industry.

CVS Stock Forecast FAQ

What is CVS’s average 12-month price target, according to analysts?

Based on analyst ratings, CVS Health Corp’s 12-month average price target is 81.73.

What is CVS’s upside potential, based on the analysts’ average price target?

CVS Health Corp has 24.76% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CVS a Buy, Sell or Hold?

CVS Health Corp has a consensus rating of Strong Buy which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.

What is CVS Health Corp’s price target?

The average price target for CVS Health Corp is 81.73. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $99.00 ,the lowest forecast is $67.00. The average price target represents 24.76% Increase from the current price of $65.51.

What do analysts say about CVS Health Corp?

CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of CVS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

CVS Health (CVS) Stock Forecast & Price Target

CVS Analyst Ratings

CVS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CVS Health

CVS Analyst Recommendation Trends

CVS Financial Forecast

CVS Earnings Forecast

CVS Sales Forecast

CVS Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts